Stocks and Investing Stocks and Investing
Wed, November 3, 2021
[ 12:00 AM ] - WOPRAI
Jake Fuller Downgraded (ZG) to Hold on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Brad Erickson Maintained (ZG) at Buy with Decreased Target to $100 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Tom White Maintained (ZG) at Strong Buy with Decreased Target to $125 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Jason Kreyer Maintained (ZG) at Strong Buy with Decreased Target to $95 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
C. Gregory Peters Maintained (AJG) at Buy with Increased Target to $180 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Andrew Bauch Initiated (AFRM) at Buy and Held Target at $220 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
George Hill Maintained (AGL) at Strong Buy with Decreased Target to $36 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Keith Weiss Maintained (AKAM) at Hold with Increased Target to $130 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Shebly Seyrafi Maintained (AKAM) at Buy with Increased Target to $135 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
James Fish Maintained (AKAM) at Buy with Increased Target to $133 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Jiong Shao Initiated (BEKE) at Buy and Held Target at $29 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Kurt Yinger Maintained (BCC) at Hold with Increased Target to $72 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Gregory Zhao Initiated (BIDU) at Buy and Held Target at $243 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Douglas Miehm Maintained (BHC) at Buy with Decreased Target to $40 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (BFAM) at Sell with Decreased Target to $130 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Mike Cyprys Maintained (BEN) at Sell with Increased Target to $30 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Timothy Horan Maintained (APPS) at Buy with Increased Target to $117 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Kennen MacKay Maintained (ADCT) at Buy with Increased Target to $34 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Frank Morgan Maintained (ADUS) at Buy with Decreased Target to $124 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Rick Schafer Maintained (VECO) at Buy with Increased Target to $34 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Jeffrey Meuler Maintained (VRSK) at Buy and Held Target at $243 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Jeffrey Silber Maintained (VRSK) at Hold and Held Target at $216 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Andrew Jeffrey Maintained (VRSK) at Strong Buy with Increased Target to $250 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Brian Abrahams Maintained (VRTX) at Buy with Increased Target to $250 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Michael Sison Maintained (WLK) at Buy with Increased Target to $130 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
TJ Schultz Maintained (WMB) at Buy with Increased Target to $32 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Matti Littunen Upgraded (WPP) to Hold and Held Target at $68 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Andrew Weisel Upgraded (WEC) to Buy and Held Target at $109 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Neil Kalton Maintained (WEC) at Buy with Decreased Target to $105 on, Nov 3rd, 2021
[ 12:00 AM ] - WOPRAI
Geulah Livshits Maintained (VYGR) at Hold with Decreased Target to $4 on, Nov 3rd, 2021

Geulah Livshits Maintained (VYGR) at Hold with Decreased Target to $4 on, Nov 3rd, 2021


Published on 2024-10-27 18:28:52 - WOPRAI, Geulah Livshits
  Print publication without navigation


Geulah Livshits of Chardan Capital, Maintained "Voyager Therapeutics, Inc." (VYGR) at Hold with Decreased Target from $5.5 to $4 on, Nov 3rd, 2021.

Geulah has made no other calls on VYGR in the last 4 months.



There is 1 other peer that has a rating on VYGR. Out of the 1 peers that are also analyzing VYGR, 0 agree with Geulah's Rating of Hold.



This is the rating of the analyst that currently disagrees with Geulah

  • Jack Allen of "Baird" Upgraded from Hold to Buy and Increased Target to $9 on, Thursday, October 7th, 2021
Contributing Sources